102 Alternatively, several groups are advocating for that incorporation of novel markers, for instance a intricate karyotype55 or epigenetic subsets, 27,28 into scientific practice. Each one of these novel prognostic and/or predictive styles will should be validated in cohorts of patients handled with focused brokers.That notwithstanding, the two s